Net Asset Value and Portfolio Update

RNS Number : 1003G
Law Debenture Corp PLC
02 November 2018
 

Net Asset Value

 

The Law Debenture Corporation p.l.c. announces that its Net Asset Value ("NAV") with borrowings at par and including fair value of IPS businesses on 31 October 2018 was 645.82 pence per share (ex income) and 656.92 pence per share (cum income).  With the Corporation's long term debt stated at fair value, the NAV was 626.35 pence per share (ex income) and 637.45 pence per share (cum income).  The mid-market price at the close of business on 31 October 2018 was 572.00 pence per share. 

 

In accordance with listing rule 15.6.8, The Law Debenture Corporation p.l.c. announces that it has no investments in other UK listed investment companies that require to be disclosed. Its top ten holdings, including all holdings with a value greater than 5% of the Corporation's gross assets as at 31 October 2018 are set out below.

 

Top 10 Holdings

 

The top 10 holdings in the investment portfolio as at 31 October 2018 were:

 

 

Rank

 

Name of Holding

% of portfolio (excl. cash)

1.

Royal Dutch Shell

4.72

2.

BP

2.67

3.

GlaxoSmithKline

2.56

4.

HSBC

2.50

5.

Senior

2.30

6.

Rio Tinto

2.10

7.

Rolls Royce

2.04

8.

Stewart Investors Pacific

1.90

9.

Hiscox

1.78

10.

Johnson Service

1.72

 

Geographical Split of investment portfolio

 

 

Region

% of portfolio

UK

62

Europe

8

North America

9

Japan

1

Other Pacific

3

Other

1

Cash and Fixed Interest

16



TOTAL

100

 

Released by The Law Debenture Corporation p.l.c., Fifth Floor, 100 Wood Street, London, EC2V 7EX (contact Ian Bowden, Company Secretariat, 020 7696 5285).

 

 

The Law Debenture Corporation p.l.c. LEI number - 2138006E39QX7XV6PP21


 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFFRLFLLIIT
UK 100